Sivik Global Healthcare Betting Big on These Five Stocks in Q4
Sivik Global Healthcare, led by Krishen Sud, has issued its latest 13F filing with the U.S.
Sivik Global Healthcare LLC manages domestic and offshore long-short equity funds focused on the healthcare sector. The funds invest globally in four major healthcare areas: services, pharmaceuticals, devices, and biotechnology. Sivik handles both client and proprietary assets.
Krishen Sud is the Managing Member of Sivik and the Portfolio Manager of the Sivik Global Healthcare Funds and their predecessor, Argus Healthcare Funds, since their inception in 2001. Before founding Sivik, Krishen was the Portfolio Manager of the Galleon Healthcare Funds, growing the firm's healthcare funds to $1.5 billion in assets from 1997 to 2001. From 1990 to 1996, he worked at Needham & Company as a Managing Director and Head of Healthcare Research, where he managed a 10-person research and banking team, provided equity research for healthcare service companies, and oversaw the healthcare investments of the Needham Emerging Growth Fund. Before Needham, Krishen was a Vice President in Investment Banking at Smith Barney. He graduated from Sydenham College, University of Bombay, and received an MBA in finance from The Wharton School, University of Pennsylvania, where he was on the Director’s Honor List.
Sivik Global Healthcare is a hedge fund with 3 clients and discretionary assets under management (AUM) of $276,782,212 (Form ADV from 2024-02-29). Their last reported 13F filing for Q1 2024 included $426,575,000 in managed 13F securities and a top 10 holdings concentration of 59.81%. Sivik Global Healthcare's largest holding is SPDR S&P 500 ETF Trust with 3,000 shares.
